Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-030300

Chief Scientific Officer sold 77,700 shares at an average $36.85 ($2,863,365)

  • Chief Scientific Officer acquired 77,700 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
ROBINS HARLAN S Chief Scientific Officer 2020-05-14 Option exercise +31,200 $6.32 $197,184 101,879 D
ROBINS HARLAN S Chief Scientific Officer 2020-05-14 Sale −3,200 $34.26 $109,632 98,679 D
ROBINS HARLAN S Chief Scientific Officer 2020-05-14 Sale −28,000 $35.44 $992,320 70,679 D
ROBINS HARLAN S Chief Scientific Officer 2020-05-15 Option exercise +35,400 $6.32 $223,728 106,079 D
ROBINS HARLAN S Chief Scientific Officer 2020-05-15 Sale −100 $33.56 $3,356 105,979 D
ROBINS HARLAN S Chief Scientific Officer 2020-05-15 Sale −400 $35.13 $14,052 105,579 D
ROBINS HARLAN S Chief Scientific Officer 2020-05-15 Sale −5,400 $36.34 $196,236 100,179 D
ROBINS HARLAN S Chief Scientific Officer 2020-05-15 Sale −22,342 $37.53 $838,495 77,837 D
ROBINS HARLAN S Chief Scientific Officer 2020-05-15 Sale −7,158 $38.11 $272,791 70,679 D
ROBINS HARLAN S Chief Scientific Officer 2020-05-18 Option exercise +11,100 $6.32 $70,152 81,779 D
ROBINS HARLAN S Chief Scientific Officer 2020-05-18 Sale −600 $38.67 $23,202 81,179 D
ROBINS HARLAN S Chief Scientific Officer 2020-05-18 Sale −10,500 $39.36 $413,280 70,679 D
Derivatives
ROBINS HARLAN S Chief Scientific Officer 2020-05-14 Option exercise · Stock Option (Right to Buy) −31,200 480,000 D
ROBINS HARLAN S Chief Scientific Officer 2020-05-15 Option exercise · Stock Option (Right to Buy) −35,400 444,600 D
ROBINS HARLAN S Chief Scientific Officer 2020-05-18 Option exercise · Stock Option (Right to Buy) −11,100 433,500 D
Open-market sales · 77,700 sh · avg $36.85 · $2,863,365
Loading xslF345X03/doc4.xml…